767 — Zhong Ji Longevity Science Income Statement
0.000.00%
Last trade - 00:00
- HK$61.48m
- HK$27.67m
- HK$64.99m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 146 | 80 | 61.1 | 89.7 | 65 |
Cost of Revenue | |||||
Gross Profit | 140 | 72.5 | 51.9 | 83.8 | 56.3 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 959 | 87.6 | 54.4 | 78.3 | 58.2 |
Operating Profit | -813 | -7.59 | 6.75 | 11.4 | 6.76 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -812 | -9.17 | 6.96 | 9.32 | 4.75 |
Provision for Income Taxes | |||||
Net Income After Taxes | -826 | -10.7 | 6.2 | 0.701 | 2.52 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -826 | -11.5 | 6.05 | -0.904 | 2.31 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -826 | -11.5 | 6.05 | -0.904 | 2.31 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.16 | -0.03 | 0.004 | -0.001 | 0.003 |